Chemopreventive mechanisms of amentoflavone: recent trends and advancements

Hardeep Singh Tuli1, Hemant Joshi2, Kanupriya Vashishth3

  • 1Department of Biotechnology, Maharishi Markandeshwar Engineering College, Maharishi Markandeshwar (Deemed to Be University), Ambala, Mullana, 133207, India.

Insights

Amentoflavone, a natural compound from plants, shows significant anticancer potential by inhibiting tumor growth, promoting cancer cell death, and blocking metastasis. Further research may lead to new cancer treatments.

Area of Science:

  • Phytochemistry
  • Pharmacology
  • Oncology

Background:

  • Growing global cancer incidence fuels research into natural anticancer agents.
  • Phytochemicals are increasingly recognized for their preclinical anticancer potential.
  • Amentoflavone, a biflavonoid from plants like Ginkgo, is a compound of interest.

Purpose of the Study:

  • To review the anticancer properties of amentoflavone.
  • To evaluate its potential as a lead compound for novel anticancer drug development.

Main Methods:

  • Literature review of preclinical studies on amentoflavone's anticancer effects.
  • Analysis of its impact on tumor growth, apoptosis, angiogenesis, and metastasis.

Main Results:

  • Amentoflavone demonstrates significant suppression of malignant growth.
  • It induces apoptosis (programmed cell death) in tumor cells.
  • Amentoflavone impedes angiogenesis and metastatic processes.

Conclusions:

  • Amentoflavone exhibits broad-spectrum anticancer activities.
  • It holds promise as a lead compound for developing new anticancer therapeutics.
  • Further in vivo studies and clinical trials are warranted to explore its therapeutic potential, alone or in combination with existing chemotherapeutics.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.2K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
288
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
395